Gonesto, Marelyn .

HRN: 12-00-35  Sex: Female

Patient Encounter


Audit Details

Audit Date
Antimicrobial
Start Date
End Date
Route
Dose
Frequency
Indication Documented
05/08/2026
METRONIDAZOLE 500MG (TAB)
05/08/2026
05/14/2026
ORAL
500mg
BID
Thickly MSAF, UTI
Checking Initial Appropriateness 

 Indication:  Empiric    Type of Infection:  Urinary TractIntra-abdominal    Compliance to guidelines: Compliant To Guidelines